We are pleased to announce the signing of a strategic partnership agreement with Pregna International Ltd., one of the world’s leading intrauterine device (IUD) manufacturers.

This collaboration marks an important milestone in advancing scalable women’s health innovation. By combining Pregna’s global manufacturing expertise and distribution capabilities with Gals Bio’s fem-wearable technology platform, the partnership aims to accelerate the development and deployment of next-generation solutions in menstrual health and diagnostics.

Through this agreement, the parties will work together to explore manufacturing alignment, regulatory pathways, and market access strategies, with the shared goal of improving women’s health around the world.

For additional details, please refer to Pregna’s official announcement [link].

Tulipon is our first Fem-Wearable device, revolutionizing women’s hygiene, wellness, and health with a single, compact vaginal device integrated with an AI-powered smartphone app.

Designed for ease of use, Tulipon is inserted just like a regular tampon using a water-dissolvable applicator, yet it functions as a menstrual cup—offering added diagnostic capabilities that: